Quantification of plasma miRNAs by digital PCR for cancer diagnosis

Biomarker Insights

Volumn 8, Issue , 2013, Pages 127-136

  Ma, Jie ^a   Li, Ning ^a   Guarnera, Maria ^a   Jiang, Feng ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Digital PCR; Lung cancer; MiRNAs; Plasma

Indexed keywords

MICRORNA; MICRORNA 21; MICRORNA 335; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER CELL; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIGITAL POLYMERASE CHAIN REACTION; DISEASE FREE SURVIVAL; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC CORRELATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LINEAR SYSTEM; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 84887629698     PISSN: 11772719     EISSN: None     Source Type: Journal    
DOI: 10.4137/BMImi.Ss13154     Document Type: Article

References (39)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
2. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomo-graphic screening. N Engl J Med. 2011;365(5):395-409.
3. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003;113(6):673-676.
4. Galasso M, Sana ME, Volinia S. Non-coding RNAs: a key to future personalized molecular therapy?Genome Med. 2010;2(2):12.
5. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834-838.
6. Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis. 2012;33(6):1126-1133.
7. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9(3):189-198.
8. Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microR-NAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila). 2012;5(3):492-497.
9. Shen J, Jiang F. Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer. Expert Opin Med Diagn. 2012;6(3):197-207.
10. Shen J, Stass SA, Jiang F. MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett. 2013;329(2):125-136.
11. Shen J, Liu Z, Todd NW, et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer. 2011;11:374.
12. Shen J, Todd NW, Zhang H, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest. 2011;91(4):579-587.
13. Dodd DW, Gagnon KT, Corey DR. Digital quantitation of potential therapeutic target RNAs. Nucleic Acid Ter. 2013;23(3):188-194.
14. Whale AS, Huggett JF, Cowen S, et al. Comparison of microfuidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res. 2012;40(11):e82.
15. Warren L, Bryder D, Weissman IL, Quake SR. Transcription factor profling in individual hematopoietic progenitors by digital RT-PCR. Proc Natl Acad Sci U S A. 2006;103(47):17807-17812.
16. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997-1006.
17. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30): 10513-10518.
18. Bhat S, Herrmann J, Armishaw P, Corbisier P, Emslie KR. Single molecule detection in nanofuidic digital array enables accurate measurement of DNA copy number. Anal Bioanal Chem. 2009;394(2):457-467.
19. Kiss MM, Ortoleva-Donnelly L, Beer NR, et al. High-throughput quantitative polymerase chain reaction in picoliter droplets. Anal Chem. 2008;80(23):8975-8981.
20. Kreutz JE, Munson T, Huynh T, Shen F, Du W, Ismagilov RF. Teoretical design and analysis of multivolume digital assays with wide dynamic range validated experimentally with microfuidic digital PCR. Anal Chem. 2011;83(21): 8158-8168.
21. Pinheiro LB, Coleman VA, Hindson CM, et al. Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantifcation. Anal Chem. 2012;84(2):1003-1011.
22. Pohl G, Shih IeM. Principle and applications of digital PCR. Expert Rev Mol Diagn. 2004;4(1):41-47.
23. Vogelstein B, Kinzler KW. Digital PCR. Proc Natl Acad Sci U S A. 1999;96(16): 9236-9241.
24. Hayden RT, Gu Z, Ingersoll J, et al. Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus. J Clin Microbiol. 2013;51(2):540-546.
25. Day E, Dear PH, McCaughan F. Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine. Methods. 2013;59(1):101-107.
26. Diehl F, Diaz LA. Digital quantification of mutant DNA in cancer patients. Curr Opin Oncol. 2007;19(1):36-42.
27. Hindson BJ, Ness KD, Masquelier DA, et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem. 2011;83(22):8604-8610.
28. Sanders R, Huggett JF, Bushell CA, Cowen S, Scott DJ, Foy CA. Evaluation of digital PCR for absolute DNA quantification. Anal Chem. 2011;83(17):6474-6484.
29. Witwer KW, McAlexander MA, Queen SE, Adams RJ. Real-time quantitative PCR and droplet digital PCR for plant miRNAs in mammalian blood provide little evidence for general uptake of dietary miRNAs: limited evidence for general uptake of dietary plant xenomiRs. RNA Biol. 2013;10(7):1080-1086.
30. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33(20):e179.
31. Heredia NJ, Belgrader P, Wang S, et al. Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samples. Methods. 2013;59(1): S20-S3.
32. Lawrie CH. MicroRNA expression in lymphoma. Expert Opin Biol Ter. 2007;7(9):1363-1374.
33. Lawrie CH, Soneji S, Marafoti T, et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 2007;121(5):1156-1161.
34. Siva AC, Nelson LJ, Fleischer CL, et al. Molecular assays for the detection of microRNAs in prostate cancer. Mol Cancer. 2009;8:17.
35. Qian B, Katsaros D, Lu L, et al. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat. 2009;117(1):131-140.
36. Tavazoie SF, Alarcón C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451(7175):147-152.
37. Ronchetti D, Lionetti M, Mosca L, et al. An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma. BMC Med Genomics. 2008;1:37.
38. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med. 2009;13(1):39-53.
39. Xie Y, Todd NW, Liu Z, et al. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer. 2010;67(2):170-176.